Canopy Growth (CGC) Return on Invested Capital (2020 - 2026)
Canopy Growth (CGC) posted Return on Invested Capital of 0.09% for Q4 2025, down 616.38% sequentially from 0.01% in Q3 2025, and down 9.0% YoY from 0.1% in Q4 2024.
Canopy Growth (CGC) Return on Invested Capital (2020 - 2026) Analysis & Trends
Canopy Growth has reported Return on Invested Capital for 6 years, with the latest figure at 0.09% in Q4 2025.
- Quarterly Return on Invested Capital fell 9.0% year-over-year to 0.09% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.09% (down 9.0% YoY) and the FY2025 annual result came in at 0.02%, down 1.0% from the prior year.
- Return on Invested Capital slipped to 0.09% in Q4 2025 per CGC's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.09% in Q4 2021 and troughed at 0.2% in Q1 2022.
- A 5-year average of 0.05% and a median of 0.01% in 2025 frame the typical range for Return on Invested Capital.
- The sharpest annual moves came in 2021 and 2022: Return on Invested Capital soared 46 bps in 2021, then dropped 13 bps in 2022.
- Over 5 years, Return on Invested Capital stood at 0.09% in 2021, then plunged by 137 bps to 0.03% in 2022, then soared by 97 bps to 0.0% in 2023, then slumped by 703 bps to 0.01% in 2024, then tumbled by 1213 bps to 0.09% in 2025.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.09%, 0.01%, and 0.01% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | -0.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.04% |
| Dec 31, 2025 | -0.09% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.07% |
| Jun 30, 2022 | -0.19% |
| Mar 31, 2022 | -0.20% |
| Dec 31, 2021 | 0.09% |
| Sep 30, 2021 | -0.13% |
| Jun 30, 2021 | -0.13% |
| Mar 31, 2021 | -0.15% |